Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × apatinib × Clear all

NCT03267121 2023-10-17

A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03096184 2018-10-09

A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03539172 2018-05-30

RASS

Phase 2 Unknown

Head & NeckSarcoma

Head and Neck Neoplasms, Sarcoma, Neoplasms, Connective and Soft Tissue

NCT02989259 2016-12-13

Apatinib for Advanced Non-squamous Head and Neck Cancer

Phase 2 Unknown

Head and Neck Neoplasms

NCT02943252 2016-10-24

The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer

Phase 2 Unknown

Head and Neck Neoplasms